A biological paradox offers new insights into the mystery of cancer

The cells in the body can be thought of as tiny archery targets, each vulnerable to the deadly arrow of cancer.  The more cells a given animal has and the

 A simple, marine-dwelling creature known as Trichoplax adhaerens has some remarkable properties. The organism can tolerate unusually high doses of radiation that would kill most other forms of life. T.

Opposites may attract when it comes to personal relationships. In political affairs today, however, that claim is becoming more difficult to assert. New research shows that common ground is shrinking in politics, and people on opposite ends of the ideological spectrum are more entrenched in their divergent positions than at any time in recent history. Those conclusions are derived not only from results of traditional opinion polls — in this era of big data and

Microorganisms are essential to maintain our health, environment, and the sustainability of buildings in which we live and work, both on Earth and during space exploration. Given that there are

PHOENIX, December 8, 2021 – OncoMyx Therapeutics, a company implementing Grant McFadden's research into cancer-killing oncolytic viruses, has just received $50M Series B funding to advance its work. McFadden directs

Editor's note: This story is part of a series of profiles of notable fall 2021 graduates.When the COVID-19 pandemic began, Nikhil Dave knew he had to do something to help. As part of his work

With the world still in the grip of a devastating pandemic, it’s hard to imagine viruses as something other than hostile enemies to be vanquished. But in a recent review article for the journal Cancers, Masmudur Rahman and Grant McFadden describe a class of viruses that act to combat rather than cause deadly disease. Such oncolytic viruses as they are known, have a remarkable ability to target and destroy cancer cells, while leaving healthy cells untouched. “The field of oncolytic

Henry (Yize) Li, PhD, Biodesign Center for Immunotherapy, Vaccines and Virotherapy Viroholics, will present as part of the Biodesign Center for Immunotherapy, Vaccines and Virotherapy Viroholics Seminar Series. Join via Zoom: https://asu.zoom.us/j/88240683626.

Masmudur Rahman, PhD, Biodesign Center for Immunotherapy, Vaccines and Virotherapy Viroholics, will present as part of the Biodesign Center for Immunotherapy, Vaccines and Virotherapy Wednesday Seminar Series. Join via Zoom: https://asu.zoom.us/j/88567521236.

Terence S. Dermody, MD, University of Pittsburgh School of Medicine, will present as part of the Biodesign Center for Immunotherapy, Vaccines and Virotherapy Viroholics Seminar Series. Join via Zoom: https://asu.zoom.us/j/88240683626.

ASU researchers see potential in wastewater When you think about wastewater — if you do at all — you probably think of reeking, worthless sewage that you flush down the

Analytics company Clarivate named Rosa Krajmalnik-Brown, director of the Biodesign Center for Health Through Microbiomes, as a 2021 Highly Cited Research across a variety of fields. This recognition is awarded to individuals in their field who demonstrate excellence through the production of highly cited papers that rank in the top 1% for their field and year in the Web of Science, a global citation database. Krajmalnik-Brown, also known as “Dr. Rosy,” has